BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23221050)

  • 1. [New insights into molecular target therapy for colorectal cancer].
    Kanemitsu K; Yamashita K; Sumi Y; Suzuki S; Tanaka K; Kakeji Y
    Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2021-30. PubMed ID: 23221050
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status and problems of molecular target therapy for colorectal cancer.
    Tsuda T; Nakajima T; Boku N
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jan; 108(1):19-23. PubMed ID: 21212591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular target therapy for colorectal cancer].
    Uetake H; Ishikawa T; Sugihara K
    Nihon Geka Gakkai Zasshi; 2011 Jan; 112(1):39-42. PubMed ID: 21387600
    [No Abstract]   [Full Text] [Related]  

  • 4. A new way to target p53-defective colorectal cancer.
    Liu Y; Wang L; Lu X
    Future Oncol; 2015; 11(23):3101-4. PubMed ID: 26549592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacoeconomics of molecular target drug: K-ras testing and cetuximab for colorectal cancer as an example].
    Shiroiwa T; Tsutani K
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():664-8. PubMed ID: 23513919
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Triage Trials in Colorectal Cancer.
    O'Hara MH; Hamilton SR; O'Dwyer PJ
    Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence of TNIK as a therapeutic target for colorectal cancer.
    Masuda M; Yamada T
    Expert Opin Ther Targets; 2017 Apr; 21(4):353-355. PubMed ID: 28281900
    [No Abstract]   [Full Text] [Related]  

  • 8. [Issues of molecular targeted therapies in combination with chemotherapy in metastatic colorectal cancer].
    Asayama M; Kadowaki S; Yamaguchi K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():464-71. PubMed ID: 22214005
    [No Abstract]   [Full Text] [Related]  

  • 9. [New molecular targeting drugs for metastatic colorectal cancer].
    Komatsu Y; Harada K; Fukushima H; Yuki S
    Nihon Rinsho; 2014 Jan; 72(1):120-6. PubMed ID: 24597359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDITORIAL: Molecularly targeted treatments for colorectal cancer: advances and limitations.
    Parodi S
    Curr Cancer Drug Targets; 2012 May; 12(4):301-2. PubMed ID: 22385508
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin, the new targeted therapy in colorectal cancer.
    Fuchs CS
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):186-9. PubMed ID: 24927268
    [No Abstract]   [Full Text] [Related]  

  • 12. The next generation of targeted therapy trials in colorectal cancer.
    O'Dwyer PJ
    Clin Adv Hematol Oncol; 2014 Dec; 12(12):852-4. PubMed ID: 25674843
    [No Abstract]   [Full Text] [Related]  

  • 13. Integration of targeted therapies with cytotoxic chemotherapy in the treatment of colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S6. PubMed ID: 20630852
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenge to optimize medical therapy for advanced colorectal cancer.
    Hubbard JM; Grothey A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt442. PubMed ID: 24511110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer].
    Takiuchi H
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():459-63. PubMed ID: 22214004
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel and Emerging Targeted Therapies of Colorectal Cancer.
    Finnberg N; Gokare P; El-Deiry WS
    Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selection of a molecule-target agent--present and prospect].
    Takahashi N; Hamaguchi T
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():482-6. PubMed ID: 22214008
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment paradigms with epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Stein S; Cohen DJ; Hochster HS
    Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S44-50. PubMed ID: 20630850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and targeted therapeutics in colorectal cancer.
    Meguerditchian AN; Bullard Dunn K
    Surg Oncol Clin N Am; 2013 Oct; 22(4):841-55. PubMed ID: 24012402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.